Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Prevention of secondary disease: preventive medicine: VIII. Oral health care.

BIBLIOGRAPHIC SOURCE(S)

  • New York State Department of Health. Prevention of secondary disease: preventive medicine. Oral health care. New York (NY): New York State Department of Health; 2008 Jul. 2 p. [2 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Preventive Oral Health Care in the Primary Care Setting

Primary care clinicians should educate patients about the importance of preventive oral health care, including dental visits; brushing, flossing, and rinsing; and the risk of developing oral cancer from use of tobacco and alcohol.

As part of the annual comprehensive physical examination, the clinician should examine the oral cavity visually and palpate the patient's lips, labial and buccal mucosa, all surfaces of the tongue and palate, and the floor of the mouth. The gingiva should be examined for signs of erythema, ulceration, or recession.

When patients present with severe dental decay, clinicians should screen for behaviors and practices that contribute to a higher risk of dental caries, including but not limited to the following:

  • Drug use, especially crack cocaine and crystal meth
  • Prolonged methadone maintenance
  • Xerostomia (decreased salivary flow)
  • Untreated dental decay
Key Point

Salivary gland disease and xerostomia may be associated with increased risk for dental caries.

Referral to Oral Healthcare Providers

Clinicians should ascertain whether their patients have a regular oral health provider and should refer all human immunodeficiency virus (HIV)-infected patients for annual hygiene and intraoral examinations, including dental caries and soft-tissue examinations.

Clinicians should promptly refer patients who present with oral mucosal, gingival, or dental lesions to an oral healthcare provider for appropriate diagnostic evaluation and treatment.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • New York State Department of Health. Prevention of secondary disease: preventive medicine. Oral health care. New York (NY): New York State Department of Health; 2008 Jul. 2 p. [2 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2008 Jul

GUIDELINE DEVELOPER(S)

New York State Department of Health - State/Local Government Agency [U.S.]

SOURCE(S) OF FUNDING

New York State Department of Health

GUIDELINE COMMITTEE

Physicians' Prevention Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Chair: Victoria L Sharp, MD, Saint Luke's Roosevelt Hospital, New York, New York

Committee Members: Bruce D Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, New York; Oladipo A Alao, MD, MPH, Harlem Hospital Center, New York, New York; Julia H Arnsten, MD, MPH, Albert Einstein College of Medicine , Montefiore Medical Center, Bronx, New York; Alvaro F Carrascal, MD, MPH, New York State Department of Health AIDS Institute, Albany, New York; Kevin Fiscella, MD, University of Rochester School of Medicine and Dentistry, Rochester, New York; Douglas G Fish, MD, Albany Medical College, Albany, New York; Donna C Futterman, MD, Children's Hospital at Montefiore, Bronx, New York; Victor K Inada, MD, APICHA Primary Care Clinic Asian & Pacific Islander Coalition on HIV/AIDS, Inc, New York, New York; Barbara E Johnston, MD, Saint Vincent's-Manhattan Comprehensive HIV Center, New York, New York; David D Kim, MD, Astor Medical Group, LLP, New York, New York; Joseph R Masci, MD, Elmhurst Hospital Center, Elmhurst, New York; David S Rubin, MD, New York Hospital Queens, Flushing, New York; Sanjiv S Shah, MD, MetroPlus Health Plan, New York, New York; Benjamin W Tsoi, MD, MPH, New York City Department of Health and Mental Hygiene, New York, New York; Rona M Vail, MD, Callen-Lorde Community Health Center, New York, New York; Milton L Wainberg, MD, New York State Psychiatric Institute, New York, New York

Clinical Education Representative: Mary Anne Brown, RN, BSN, MA, Upper Hudson Primary Care Consortium, Glens Falls, New York

Liaison: M Monica Sweeney, MD, MPH, Liaison to the New York City Department of Health and Mental Hygiene, Bureau of HIV/AIDS Prevention and Control, New York, New York

AIDS Institute Staff Liaisons: L Jeannine Bookhardt-Murray, MD, Harlem United Community AIDS Center, New York, NY; Daniel A O'Connell, New York State Department of Health AIDS Institute, Albany, New York

Principal Contributors: Stuart Fischman, DMD, SUNY at Buffalo, Buffalo

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on September 2, 2008.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo